Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells

Joint Authors

Liao, Hui-Fen
Hsieh, Chen-Hsi
Chao, K. S. Clifford
Chen, Yu-Jen

Source

Evidence-Based Complementary and Alternative Medicine

Issue

Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-11, 11 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2013-09-02

Country of Publication

Egypt

No. of Pages

11

Main Subjects

Medicine

Abstract EN

Cancer stem cells (CSCs) existing in human cancers have been demonstrated to be a major cause of cancer treatment resistance, invasion, metastasis, and relapse.

Self-renewal pathways, Wnt/β-catenin, Sonic hedgehog (Shh), and the Notch signaling pathway play critical roles in developing CSCs and lead to angiogenesis, migration, invasion, and metastasis.

Multidrug resistance (MDR) is an unfavorable factor causing the failure of treatments against cancer cells.

The most important and thoroughly studied mechanism involved in MDR is the active efflux of chemotherapeutic agents through membrane drug transporters.

There is growing evidence that Norcantharidin (NCTD), a water-soluble synthetic small molecule derivative of naturally occurring cantharidin from the medicinal insect blister beetle (Mylabris phalerata Pallas), is capable of chemoprevention and tumor inhibition.

We summarize investigations into the modulation of self-renewal pathways and MDR in CSCs by NCTD.

This review may aid in further investigation of using NCTD to develop more effective strategies for cancer treatment to reduce resistance and recurrence.

American Psychological Association (APA)

Hsieh, Chen-Hsi& Chao, K. S. Clifford& Liao, Hui-Fen& Chen, Yu-Jen. 2013. Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells. Evidence-Based Complementary and Alternative Medicine،Vol. 2013, no. 2013, pp.1-11.
https://search.emarefa.net/detail/BIM-502226

Modern Language Association (MLA)

Hsieh, Chen-Hsi…[et al.]. Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells. Evidence-Based Complementary and Alternative Medicine No. 2013 (2013), pp.1-11.
https://search.emarefa.net/detail/BIM-502226

American Medical Association (AMA)

Hsieh, Chen-Hsi& Chao, K. S. Clifford& Liao, Hui-Fen& Chen, Yu-Jen. Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells. Evidence-Based Complementary and Alternative Medicine. 2013. Vol. 2013, no. 2013, pp.1-11.
https://search.emarefa.net/detail/BIM-502226

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-502226